haloperidol has been researched along with doxepin in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (42.42) | 18.7374 |
| 1990's | 4 (12.12) | 18.2507 |
| 2000's | 9 (27.27) | 29.6817 |
| 2010's | 6 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Booth, RG; Brown, RL; Bucholtz, EC; Tropsha, A; Wyrick, SD | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Balogh, I; Kim, HY; Koczok, K; Korade, Z; Liu, W; Mirnics, K; Porter, NA; Tallman, KA; Xu, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Richelson, E | 1 |
| Baker, GA; Blumenstein, J; Santalo, R | 1 |
| Baldessarini, RJ; Granacher, RP | 1 |
| Warneke, L | 1 |
| Hussey, HH | 1 |
| Eikmeier, G; Gastpar, M; Kastrup, O | 1 |
| Orthen-Gambill, N; Salomon, M | 1 |
| Beil, W; Hannemann, H; Sewing, KF | 1 |
| Borbe, HO; Dimpfel, W; Spüler, M | 1 |
| Lassen, JB | 1 |
| Dorsch, C; Malinow, KL | 1 |
| Ortiz, A | 1 |
| Shapiro, S | 1 |
| Foxworth, JM; Klontz, W; Pary, RJ | 1 |
| Beneke, M; Fritze, J; Rasmus, W; Rød, IS | 1 |
| Brockington, IF; Klauwer, C; Kornhuber, J; Lanczik, M; Walloch, JE | 1 |
| Krzek, J; Maślanka, A; Szlósarczyk, M; Wach, K; Żmudzki, P | 1 |
2 review(s) available for haloperidol and doxepin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Delusional denial of pregnancy as a special form of Cotard's syndrome: case report and review of the literature.
Topics: Adrenergic Uptake Inhibitors; Antipsychotic Agents; Delusions; Denial, Psychological; Doxepin; Female; Haloperidol; Humans; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Third; Schizophrenia; Schizophrenic Psychology; Syndrome | 2007 |
31 other study(ies) available for haloperidol and doxepin
| Article | Year |
|---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Synthesis, evaluation, and comparative molecular field analysis of 1-phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes as ligands for histamine H(1) receptors.
Topics: Animals; Binding Sites; Binding, Competitive; Brain; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ligands; Models, Molecular; Pyrilamine; Radioligand Assay; Structure-Activity Relationship; Tetrahydronaphthalenes | 1999 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations | 2002 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The Effect of Small Molecules on Sterol Homeostasis: Measuring 7-Dehydrocholesterol in Dhcr7-Deficient Neuro2a Cells and Human Fibroblasts.
Topics: Animals; Cell Line; Dehydrocholesterols; Dose-Response Relationship, Drug; Fibroblasts; Homeostasis; Humans; Mice; Molecular Conformation; Neurons; Oxidoreductases Acting on CH-CH Group Donors; Small Molecule Libraries; Sterols; Structure-Activity Relationship | 2016 |
Tricyclic antidepressants and histamine H1 receptors.
Topics: Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Atropine; Benztropine; Cells, Cultured; Clozapine; Cyproheptadine; Desipramine; Doxepin; Haloperidol; Histamine H1 Antagonists; Hydroxyzine; Imipramine; Mice; Neoplasms, Experimental; Neuroblastoma; Nortriptyline; Protriptyline; Receptors, Histamine; Receptors, Histamine H1; Receptors, Muscarinic | 1979 |
Effect of psychotropic agents upon the blastogenic response of human t-lymphocytes.
Topics: Chlorpromazine; Depression, Chemical; DNA; Dopamine; Doxepin; Drug Synergism; Fluphenazine; Haloperidol; Humans; In Vitro Techniques; Lymphocyte Activation; Osmolar Concentration; Prochlorperazine; Proteins; RNA; T-Lymphocytes; Thiothixene; Thymidine; Tranquilizing Agents; Trifluoperazine; Uridine | 1977 |
Physostigmine. Its use in acute anticholinergic syndrome with antidepressant and antiparkinson drugs.
Topics: Acute Disease; Adult; Amitriptyline; Benztropine; Chemical Phenomena; Chemistry; Cholinesterase Inhibitors; Doxepin; Female; Haloperidol; Humans; Male; Nervous System Diseases; Parasympatholytics; Physostigmine; Psychoses, Substance-Induced; Syndrome; Thioridazine | 1975 |
A case of manic-depressive illness in childhood.
Topics: Adolescent; Age Factors; Alberta; Bipolar Disorder; Child; Chlorpromazine; Doxepin; Electroconvulsive Therapy; Electroencephalography; Haloperidol; Humans; Lithium; Male; Psychological Tests | 1975 |
Editorial: Physostigmine: value in treatment of central toxic effects of anti-cholinergic drugs.
Topics: Amitriptyline; Benztropine; Brain; Doxepin; Haloperidol; Humans; Injections, Intramuscular; Mental Disorders; Parasympatholytics; Physostigmine; Thioridazine | 1975 |
[Central anticholinergic intoxication syndrome. A contribution to the differential diagnosis of exogenous psychoses].
Topics: Akathisia, Drug-Induced; Biperiden; Diagnosis, Differential; Doxepin; Dysarthria; Dyskinesia, Drug-Induced; Ethanol; Fever; Hallucinations; Haloperidol; Humans; Male; Middle Aged; Mydriasis; Skin; Substance Withdrawal Syndrome; Tachycardia; Urinary Retention | 1991 |
Differential effects of psychotropic drugs on feeding in rats: is histamine blockade involved?
Topics: Animals; Desipramine; Diet; Doxepin; Drinking; Eating; Haloperidol; Histamine Antagonists; Male; Promazine; Psychotropic Drugs; Rats; Rats, Inbred Strains | 1990 |
Interaction of antidepressants and neuroleptics with histamine stimulated parietal cell adenylate cyclase and H+ secretion.
Topics: Adenylyl Cyclases; Animals; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Doxepin; Gastric Acid; Guinea Pigs; Haloperidol; Histamine Antagonists; Parietal Cells, Gastric; Trifluoperazine; Trimipramine | 1988 |
Monitoring of the effects of antidepressant drugs in the freely moving rat by radioelectroencephalography (tele-stereo-EEG).
Topics: Amitriptyline; Animals; Antidepressive Agents; Arousal; Brain; Dextroamphetamine; Doxepin; Electroencephalography; Haloperidol; Imipramine; Lysergic Acid Diethylamide; Male; Microcomputers; Nomifensine; Rats; Rats, Inbred F344; Signal Processing, Computer-Assisted; Telemetry | 1988 |
The effect of p-chloroamphetamine on motility in rats after inhibition of monoamine synthesis, storage, uptake and receptor interaction.
Topics: Amitriptyline; Amphetamine; Animals; Biogenic Amines; Catecholamines; Chlorine; Chlorpheniramine; Chlorpromazine; Desipramine; Dibenzazepines; Dose-Response Relationship, Drug; Doxepin; Female; Haloperidol; Imipramine; Methyltyrosines; Motor Activity; Rats; Receptors, Cholinergic; Serotonin Antagonists; Spiro Compounds; Time Factors | 1974 |
Tricyclic precipitation of steroid psychosis.
Topics: Doxepin; Drug Interactions; Female; Haloperidol; Humans; Middle Aged; Prednisone; Psychoses, Substance-Induced | 1984 |
Neuropharmacological profile of Meige's disease: overview and a case report.
Topics: Aged; Baclofen; Benztropine; Clonazepam; Doxepin; Drug Therapy, Combination; Dystonia; Facial Muscles; Haloperidol; Humans; Levodopa; Male; Spasm | 1983 |
Depression in a patient with dementia secondary to cerebrotendinous xanthomatosis.
Topics: Depressive Disorder; Doxepin; Haloperidol; Humans; Lipidoses; Male; Middle Aged; Neurocognitive Disorders; Xanthomatosis | 1983 |
Cholinergic rebounds and withdrawal syndromes.
Topics: Benztropine; Doxepin; Haloperidol; Humans; Male; Receptors, Cholinergic; Substance Withdrawal Syndrome | 1980 |
Correct titration of non-drugs and some other methodological issues.
Topics: Administration, Oral; Amitriptyline; Anxiety Disorders; Benperidol; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Doxepin; Drug Administration Schedule; Flupenthixol; Fluspirilene; Haloperidol; Humans; Imipramine; Injections, Intramuscular; Promethazine; Psychotropic Drugs; Pyrimidines; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Single-Blind Method | 1994 |
Dependence of the kinetic and thermodynamic parameters on hydrophilic-lipophilic character of alprazolam, clonazepam, diazepam, doxepin and haloperidol in alkaline environment.
Topics: Alprazolam; Clonazepam; Diazepam; Doxepin; Drug Stability; Haloperidol; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kinetics; Thermodynamics | 2013 |